期刊文献+

胃癌组织中HER-2和Survivin蛋白的表达及临床意义 被引量:4

Expression and Clinical Significance of HER-2 and Survivin in Gastric Cancer Tissue
下载PDF
导出
摘要 目的探讨胃癌组织中HER-2和Survivin蛋白的表达情况以及二者与临床病理特征的关系。方法采用免疫组化方法及图像分析技术分别对70例胃癌组织中HER-2和Survivin蛋白的表达情况进行检测,并分析二者与胃癌患者临床病理学参数的关系。结果胃癌组织中HER-2和Survivin蛋白的表达与分化程度、TNM分期及淋巴结转移有关(均P<0.05),与性别、年龄及肿瘤大小无关。阳性率相关性分析及蛋白半定量相关性分析均显示HER-2蛋白与Survivin蛋白表达呈正相关(均P<0.01)。结论 HER-2和Survivin蛋白的表达均与分化程度、TNM分期及淋巴结转移有关,且胃癌组织中HER-2蛋白和Survivin蛋白之间具有正向调节关系。 Objective To investigate the expression of human epidermal growth factor receptor-2(HER-2)and Survivin protein in gastric cancer tissue,and explore its relationship with clinicopathological characteristics. Methods Immunohistochemistry assay was used for detection of HER-2 and Survivin protein expression in 70 gastric cancer biopsy samples. The relationship with the clinicoathological parameters in patients with gastric cancer was analyzed. Results The expression of HER-2 and Survivin protein was correlated with tumor differentiation,TNM stage and lymph node metastasis(all P〈0.05),but not with sex,age,the diameter of tumor. The correlation analysis of positive rate and the semi-quantitative protein expression showed that the expression of Survivin and HER-2 was significantly positively related(all P〈0.01). Conclusion The positive expression of HER-2 and Survivin protein in gastric cancer correlates with tumor differentiation,TNM stage and lymph node metastasis. HER-2 expression significantly correlates with Survivin at the protein level in gastric cancer tissues.
出处 《中国医科大学学报》 CAS CSCD 北大核心 2016年第7期616-619,共4页 Journal of China Medical University
基金 辽宁省科学技术计划(2014022016)
关键词 胃癌 HER-2 SURVIVIN gastric cancer human epidermal growth factor receptor-2 Survivin
  • 相关文献

参考文献1

二级参考文献11

  • 1Jiyuan Yang,Hesheng Luo,Yan Li,Junchuan Li,Zhiqiang Cai,Xiaoyan Su,Danqing Dai,Wei Du,Tingxuan Chen,Ming Chen.Intratumoral Heterogeneity Determines Discordant Results of Diagnostic Tests for Human Epidermal Growth Factor Receptor (HER) 2 in Gastric Cancer Specimens[J].Cell Biochemistry and Biophysics.2012(1)
  • 2Albarello L,Pecciarini L,Doglioni C.HER2 testing in gastric cancer[].Advances in Anatomic Pathology.2011
  • 3J Rüschoff,I Nagelmeier,G Baretton,M Dietel,H H?fler,HU Schildhaus,R Büttner,W Schlake,O Stoss,HH Kreipe.HER2 testing in gastric cancer. What is different in comparison to breast cancer?[].Pathologe.2010
  • 4Bang YJ.Advances in the management of HER2-positive ad- vanced gastric and gastroesophageal junction cancer[].Journal of Clinical Gastroenterology.2012
  • 5J rgensen JT,Hersom M.HER2as a Prognostic Marker in Gastric Cancer-A Systematic Analysis of Data from the Literature[].Journal du Cancer.2012
  • 6Rüschoff J,Hanna W,Bilous M,Hofmann M,Osamura RY,Penault-Llorca F,van de Vijver M,Viale G.HER2 testingin gastric cancer: a practical approach[].Modern Pathology.2012
  • 7Hofmann M,Stoss O,Shi D,Büttner R,van de Vijver M,KimW,Ochiai A,Rüschoff J,Henkel T.Assessment of a HER2scoring system for gastric cancer: results from a validationstudy[].Histopathology.2008
  • 8Park YS,Hwang HS,Park HJ,Ryu MH,Chang HM,Yook JH,Kim BS,Jang SJ,Kang YK.Comprehensive analysis of HER2expression and gene amplification in gastric cancers usingimmunohistochemistry and in situ hybridization: whichscoring system should we use[].Human Pathology.2012
  • 9Fox SB,Kumarasinghe MP,Armes JE,Bilous M,Cum-mings MC,Farshid G,Fitzpatrick N,Francis GD,McCloudPI,Raymond W,Morey A.Gastric HER2 Testing Study (GaTHER): an evaluation of gastric/gastroesophagealjunction cancer testing accuracy in Australia[].The American Journal of Surgical Pathology.2012
  • 10Bickenbach K,Strong VE.Comparisons of Gastric CancerTreatments: East vs.West[].J Gastric Cancer.2012

共引文献12

同被引文献41

引证文献4

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部